(NewsTarget) Is it possible to mitigate the damaging effects of covid “vaccine” spike proteins through simple nutrition? A new study published in the journal Viruses seems to suggest so.
Australian researchers looked at two common nutritional supplements – bromelain and acetylcysteine (BromAc) – that are capable of unfolding the structures that hold spike proteins together, effectively neutralizing them.
Severe acute respiratory syndrome coronavirus, also known as SARS-CoV-2, is demarcated by a spike glycoprotein and envelope protein that contains disulfide bridges for stabilization. They bind to the ACE2 receptor in host cells present in the nasal mucosa, triggering infection.
A BromAc treatment, the team found, is capable of “synergistic action against glycoproteins” in that the nutritional duo breaks apart the glycosidic linkages and disulfide bonds, reducing or even eliminating the ability of spike proteins to cause covid infection.
These same spike proteins, just to clarify, are present inside all of the so-called “vaccines” currently available to the public. Some would argue that the only source of these spike proteins is the injections, and that covid itself does not exist since the alleged virus has never been isolated.
“We sought to determine the effect of BromAc on the spike and envelope proteins and its potential to reduce infectivity in host cells,” the paper reads. “Recombinant spike and envelope SARS-CoV-2 proteins were disrupted by BromAc. Spike and envelope protein disulfide bonds were reduced by Acetylcysteine.”
“In in vitro whole virus culture of both wild-type and spike mutants, SARS-CoV-2 demonstrated a concentration-dependent inactivation from BromAc treatment but not from single agents. Clinical testing through nasal administration in patients with early SARS-CoV-2 infection is imminent.”
Is BromAc a natural solution for covid jab spike protein damage?
While treatment with acetylcysteine alone did not show any alteration of spike proteins, a combination of acetylcysteine and bromelain, or BromAc, at 50 and 100µ g/20 mg/mL and 50 and 100µ g/mL, respectively, resulted in significant protein alteration.